Latest from @CombatCancer on Twitter

With our partner @MedenInmed at the University Hospital in Fuenlabrada (Madrid); Prof.Murawa and Dr.Cieciorowski watching CRS + PRS HIPEC cases @CombatCancer #HIPEC #PRS

@CombatCancer participará con un stand virtual en el Workshop de GECOP @operaelcancer organizado por el Dr.Fernando Pereira del HU Fuenlabrada los días 10 y 11 de Junio - visítenos y recibirá más información acerca de #HIPEC con la técnica cerrada y agitada PRS+Agitación por CO2

@CombatCancer participará con un stand virtual en el Workshop de GECOP @operaelcancer organizado por el Dr.Fernando Pereira del HU Fuenlabrada los días 10 y 11 de Junio - visítenos y recibirá más información acerca de #HIPEC con la técnica cerrada y agitada PRS+Agitación por CO2

🇵🇱First successful Combat PRS+A-HIPEC Cases after CRS done at the Lower Silesian Oncology Institute in Wroclaw last week🇵🇱 with our local partner Meden-Inmed Sp. z o.o.!
Many thanks to Prof.Dr.Bebenek and his team for the opportunity.@CombatCancer @ESSOnews @operarelcancer #HIPEC

Great results from our friends @DukeUrology on the use of HIVEC in the USA.

“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”

👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman

#BladderCancer #Cancer #HIVEC



https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542

Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC

"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...

www.urologytimes.com

Here I go again, this treatment is amazing and I’m so grateful to ⁦@NorthBristolNHS⁩ #urology for providing this ‘maintenance’ #bladdercancer ⁦@CombatCancer⁩ ⁦@Actionbladderca⁩

@alarjosan @HUReinaSofia @IMIBIC @GECOP_ @operarelcancer @SPeritoneum @aecirujanos @ESSOnews @Hospital_FJD Congrats @alarjosan and team!
Proud to be working with you!
👏🏻👏🏻👏🏻👏🏻👏🏻

Load More...